Skip to main content
HCPCS J2183 · Level II · Part B drug

HCPCS J2183: Injection, meropenem (wg critical care), not therapeutically equivalent to

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J2183

Billing unit
100 MG
Inj meropenem (wg crit care)
ASP payment limit
$1.339
October 2026; -4.9% vs July 2026
Practitioner MUE
60
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2183 is the Level II code for Injection, meropenem (wg critical care), not therapeutically equivalent to, billed per 100 MG. The Medicare Part B ASP payment limit for October 2026 is $1.339 per billing unit, down 4.9% from July 2026. The practitioner MUE allows up to 60 units per date of service (MAI 3). Under OPPS it carries status indicator N. J2183 is billed in units of 100 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 2 NDCs to it, sold as Meropenem by WG Critical Care, LLC, Mylan Institutional LLC. No current Billing and Coding Article lists J2183, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2183 at $1.339 per 100 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.408 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2183
QuarterPayment limitPerCoinsurance
October 2026$1.339100 MG20%
July 2026$1.408100 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 2 labelers to J2183. Report the NDC in the claim's drug segment and bill the number of J2183 units that equals the quantity administered divided by 100 MG; the last column gives units per full package.

NDCs that crosswalk to J2183
NDCDrug nameLabelerPackage sizeBilling units / package
44567-0402-06MeropenemWG Critical Care, LLC1 × 6120
72078-0081-06MeropenemMylan Institutional LLC1 × 6120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2183. For practitioners the limit is 60 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2183 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services603 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital603 Date of Service Edit: ClinicalPrescribing Information
DME supplier603 Date of Service Edit: ClinicalPrescribing Information

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2183 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

J2183 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2183 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J2183 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J2183 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J2183 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Frequently asked questions — HCPCS J2183

What does HCPCS code J2183 describe?

J2183 is defined by CMS as "Injection, meropenem (wg critical care), not therapeutically equivalent to". Each billing unit represents 100 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J2183 in October 2026?

The ASP-based payment limit is $1.339 per 100 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $1.408.

How many units of J2183 can be billed per day?

The practitioner Medically Unlikely Edit is 60 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J2183?

The October 2026 ASP crosswalk lists 2 NDCs from 2 labelers: Meropenem (WG Critical Care, LLC); Meropenem (Mylan Institutional LLC). For example NDC 44567-0402-06 is a 1 package equal to 120 billing units. The crosswalk's billing-units-per-package figure converts each package into J2183 units.

Does J2183 have NCCI bundling edits?

No active practitioner PTP pairs list J2183 as a column-1 or column-2 code in the v323r0 release. Unit limits (MUE) and medical-necessity coverage rules still apply.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.